Stock screenerAll disclosures → EDGAR →
NVCT
Conviction 100HealthcareScan · Thu, Jun 25, 2026NVCT$27.89+13.93%
ResistanceSupportVol 14Vol MA14 325.11K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price27.89
Change+13.93%
Gap+2.04%
Rel volume7.92×
Avg volume249.79K
Avg $ vol5.06M
SMA 2012.72
SMA 5010.95
SMA 2008.29
Price vs 50+154.68%
Price vs 200+236.29%
MA stackbullish
50/200 cross—
Supertrendup · 19.59
RSI (14)94
MACD hist1.72
MACD crossbull · 8d
Stoch %K / %D100 / 97
ADX (14)44
+DI / −DI69 / 3
RSI divergence—
MACD divergence—
ATR %+6.03%
ADR %8.57%
52w high27.89
52w low5.65
From 52w high+0.00%
Above 52w low+393.63%
New 52w highYes
SqueezeOff
Bollinger width158.80%
%B1.25
Donchian pos100.00%
Donchian high27.89
Donchian low9.22
AVWAP (52w high)26.43
vs AVWAP high+5.54%
AVWAP (52w low)11.89
vs AVWAP low+134.57%
OBV trendUp
Chaikin MF (20)0.73
Today vs 20d7.92×
Avg vol (14d)325.11K
Avg vol (20d)249.79K
Avg $ vol (20d)5.06M
Market cap739.8M
RS 3m (vs SPY)+195.67%
RS 6m (vs SPY)+206.92%
RS line new highYes
Trend template8/8
Technical rank98.8
1 week+121.53%
1 month+176.14%
3 months+250.38%
6 months+237.65%
1 year+249.50%
YTD+227.73%
P/E-27.98
P/B52.03
P/S—
P/FCF—
EPS-1.32
Div yield—
ROE-185.95%
ROA-104.11%
Debt/Eq—
Current2.27
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-39.17%
Price target27.75
Target upside-0.50%
Analyst ratingBuy
Institutional20.19%
Ent. value714.67M
Revenue—
Net income-6.05M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out26.53M
Employees13
ListedFri, Feb 4, 2022
Free float15.47M
Float %58.4%
Short interest1.58M
Days to cover13.6d
Short volume50.5%
Squeeze score67 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.25 · 2 est
Last EPS vs est−$0.26 vs −$0.30
Last surprise+13.3% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank98.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance12.37
Support8.82
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NVCT
No recent disclosed trades by Congress in NVCT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NVCT
No recent insider (Form 4) filings in NVCT. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in NVCT · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.